Viroimmunotherapy

Oncolytic Viroimmunotherapy Improved by Enhanced Cytokine Transgene Expression
Oncolytic Viroimmunotherapy Improved by Enhanced Cytokine Transgene Expression 150 150 Lauren Dembeck

Researchers were able to suppress in vivo tumor growth with an oncolytic virus by enhancing the production of the cytokine interleukin-12 in the tumors. Malignant peripheral nerve sheath tumors (MPNSTs) are rare, aggressive sarcomas that exhibit resistance to non-surgical treatment and have high rates of metastasis and relapse. The prognosis for MPNSTs is poor, with…